December 2023
-
12.29.2023 Updates & Statements Albert Bourla Covid-19 Leadership Oncology Rare Diseases December Social Media Round-Up—Welcome Seagen, US/India CEO Forum, AI, and Gratitude -
12.15.2023 Updates & Statements Covid-19 Diseases & Conditions Influenza Pneumoccocal Disease Pneumonia Respiratory Syncytial Virus Technology Pfizer Launches VaxAssist, to Help Individual’s Assess Respiratory Vaccine Eligibility -
12.04.2023 Updates & Statements Albert Bourla Covid-19 Diversity & Inclusion Leadership November Social Media Round-Up—Vaccine Anniversary, Transgender Awareness, and the Corporate Equality Index
November 2023
-
11.29.2023 Updates & Statements Covid-19 Diseases & Conditions Medicines Wellness Pfizer’s 2-in 1 At-Home Test Enables Convenient Testing for both COVID-19 and the Flu -
11.01.2023 Updates & Statements Albert Bourla Business Covid-19 Diversity & Inclusion Leadership Responsibility October Social Media Round-Up—Israel-Hamas War, COVID-19 Treatment News, and Pfizer Makes Forbes List
October 2023
-
10.30.2023 Updates & Statements Covid-19 Diseases & Conditions Government Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution -
10.27.2023 Perspectives Covid-19 Diseases & Conditions Health Equity Influenza Partnerships Research Respiratory Syncytial Virus Vaccines The Power of Partnership in our Mission to Better Connect the Patient Health Journey -
10.16.2023 Covid-19 Diseases & Conditions Influenza mRNA Research Respiratory Syncytial Virus Vaccines Easing the Healthcare Burden of the Seasonal Triple-demic and Pfizer’s Unwavering Commitment to Public Health -
10.06.2023 Updates & Statements Albert Bourla Covid-19 History Research Vaccines Nobel Prize Awarded to Scientists Responsible for mRNA Breakthrough
September 2023
-
09.14.2023 Updates & Statements Covid-19 Diseases & Conditions Vaccines Wellness This Season’s COVID-19 Vaccine Rolls Outs Across U.S.
May 2023
-
05.18.2023 Covid-19 Partnerships Research Research!America Offers $200k Discovery | Innovation | Health Prize for COVID-19 Innovator -
05.11.2023 Covid-19 Diseases & Conditions Health Equity Vaccines Global and U.S. Agencies Declare End of COVID-19 Emergency